KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
Clinical trial NCT04165798 · RECRUITING
Trial details
- NCT number
- NCT04165798
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-19
- Primary completion
- 2032-02-13
- Enrollment
- 1065
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.